NEW ORLEANS--(BUSINESS WIRE)--Today, MiniVax, Inc. (MiniVax), a company specializing in the development of treatments for opportunistic fungal and bacterial infections, announced Dr. Bruce Beutler as the most recent addition to its Scientific Advisory Board. Dr. Beutler has over 25 years of experience in immunology research and is currently Director of the Center for the Genetics of Host Defense at the University of Texas Southwestern Medical Center. Dr. Beutler has made numerous significant achievements in the study of immunology and was recently a co-recipient of the 2011 Nobel Prize in Medicine for the discovery of the key mammalian sensors of microbial infections. Dr. Beutler’s expertise in the field of immunology will be of considerable value for MiniVax as it plans the next steps of product development for its vaccine and monoclonal antibody therapeutic against Pneumocystis pneumonia (PCP), the most common opportunistic infection in HIV/AIDS patients.
